Business Context and Reporting Period
Company: Care Investment Trust Inc. (Note: Input metadata referenced "TIPTREE INC." but the filing text identifies the registrant as Care Investment Trust Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2008
Business Overview: A Maryland-domiciled Real Estate Investment Trust (REIT) externally managed by CIT Healthcare LLC. The Company invests in healthcare-related commercial mortgage debt and real estate, including skilled nursing facilities, assisted living, and medical office buildings. Operations commenced on June 22, 2007; therefore, no prior-year comparative data is available.
Key Financial Metrics
| Metric | Value (in thousands) |
|---|---|
| Total Assets | $339,372 |
| Total Liabilities | $48,965 |
| Stockholders' Equity | $290,407 |
| Total Revenues | $4,834 |
| Net Income | $459 |
| Net Cash Provided by Operating Activities | $2,277 |
| Net Cash Used in Investing Activities | ($12,603) |
| Net Cash Provided by Financing Activities | $9,896 |
| Cash and Cash Equivalents (Ending) | $14,889 |
| Outstanding Debt (Warehouse Line) | $38,496 |
| Earnings Per Share (Basic & Diluted) | $0.02 |
Portfolio Composition: Investments in loans totaled $246.2 million (77% of portfolio), investments in partially-owned entities totaled $71.1 million (22%), and net leased property totaled $3.0 million (1%). The loan portfolio had an effective yield of 7.85% for the quarter.
Material Changes and Operational Highlights
- Investment Activity: The Company originated $10.3 million in new loans and invested $2.97 million in a net leased property (Sioux City II) during the quarter. Net cash used for investing activities was $12.6 million.
- Debt Utilization: Borrowings under the warehouse line of credit increased from $25.0 million at year-end 2007 to $38.5 million at March 31, 2008, to fund new investments.
- Losses: The Company recorded a $1.1 million loss from investments in partially-owned entities (primarily Cambridge properties) and a $0.2 million unrealized loss on derivative instruments.
- Distributions: The Company declared and paid distributions of $3.6 million on common stock during the quarter.
Outlook, Risks, and Management Commentary
- Market Conditions: Management highlights significant dislocations in global credit markets and a contraction of liquidity in securitized financing (CDOs and CMBS). This has hampered the Company's original intent to leverage mortgage investments through securitization.
- Strategic Shift: In response to credit market turmoil, the Company has redirected focus toward high-quality healthcare real estate equity investments while maintaining opportunistic mortgage lending.
- Liquidity Risks: The Company relies on a $300 million warehouse facility with Column Financial, Inc. (affiliate of Credit Suisse). Management notes that additional funds cannot be assured due to market conditions. If a securitization is not consummated, the warehouse provider could liquidate collateral, potentially resulting in losses.
- Legal Proceedings: A class action lawsuit was filed in September 2007 alleging the IPO registration statement failed to disclose asset impairments and financing difficulties. The Company intends to defend vigorously; no loss provision has been accrued.
- Subsequent Events: On April 15, 2008, a borrower prepaid a $27.2 million loan, resulting in a $0.3 million loss due to unamortized premium. On May 14, 2008, the Company entered an agreement to acquire a $100+ million portfolio of healthcare facilities.
Investor Verification Checklist
- Securitization Status: Verify the current status of plans to issue CDOs or CMBS, as the inability to execute these transactions poses a significant liquidity risk.
- Warehouse Line Availability: Confirm the current utilization and remaining availability of the $300 million warehouse facility with Column Financial, Inc., given the lender's discretion in underwriting.
- Legal Exposure: Monitor the progress of the class action lawsuit regarding the IPO and potential financial impact of defense costs or settlements.
- Portfolio Yield vs. Cost: Assess the spread between the 7.85% effective yield on loans and the rising cost of the warehouse line (LIBOR + 0.75%, increasing to 1.0% in June 2008).
- Equity Investment Performance: Review the performance of the Cambridge joint venture, which contributed a $1.4 million equity loss in the quarter.